Phenols
![eMolecules 1421263-30-0 | 4-(4-Hydroxyphenyl)-2-[4-(trifluoromethyl)phenyl]-thiazole | Oakwood Chemicals | MFCD22683009 | 321.320 | C16H10F3NOS | 97.000 | Oc1ccc(cc1)-c1csc(n1)-c1ccc(cc1)C(F)(F)F | 1g | 480147747](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502142733.JPG-250.jpg)
eMolecules 1421263-30-0 | 4-(4-Hydroxyphenyl)-2-[4-(trifluoromethyl)phenyl]-thiazole | Oakwood Chemicals | MFCD22683009 | 321.320 | C16H10F3NOS | 97.000 | Oc1ccc(cc1)-c1csc(n1)-c1ccc(cc1)C(F)(F)F | 1g | 480147747
4-(4-Hydroxyphenyl)-2-[4-(trifluoromethyl)phenyl]-thiazole | Oakwood Chemicals | 1421263-30-0 | MFCD22683009 | 321.320 | C16H10F3NOS | 97.000 | Oc1ccc(cc1)-c1csc(n1)-c1ccc(cc1)C(F)(F)F | 1g | 480147747
Medchemexpress LLC 4-hydroxybenzoic acid | 99-96-7 | MFCD00002547 | 100.0% | 138.12 g/mol | C7H6O3 | 1g
4-Hydroxybenzoic acid a phenolic derivative of benzoic acid could inhibit most gram-positive and some gram-negative bacteria with an IC50 of 160 g/mL
Pfaltz & Bauer p-Nitrophenol sodium salt Tech 100G | 824-78-2
p-Nitrophenol sodium salt Tech 100G | 824-78-2
Medchemexpress LLC FHD-609 | 2676211-64-4 | C47H56N8O6 | 1 G
FHD-609 is a PROTAC degrader and inhibitor of BRD9 (Bromodomain-containing protein 9). It targets ncBAF and can be used for research on a wide range of cancers that contain a mutation in a BAF complex subunit. When combined with Telomelysin or INO5401, FHD-609 may have a role in adrenocortical carcinoma (ACC) treatment.
- PROTAC degrader and inhibitor of BRD9 (Bromodomain-containing protein 9).
- Targets ncBAF.
- Applicable for research into cancers with a mutation in a BAF complex subunit.
- Potential for adrenocortical carcinoma (ACC) treatment in combination with Telomelysin or INO5401.
- Purity: 98.95%.
- Molecular weight: 829.00.
- Formula: C47H56N8O6.
- Appearance: Solid, white to off-white.
Medchemexpress LLC Fhd-609 | 2676211-64-4 | 99.2% | 829.00 | C47H56N8O6 | 10 MG
FHD-609 is a selective heterobifunctional degrader (PROTAC) of bromodomain-containing protein 9 (BRD9). It induces targeted proteasomal degradation via CRBN recruitment and is used in research to study BRD9 biology, ncBAF complex function, and oncology-related applications. The compound is supplied as a high-purity material for laboratory use and formulation work.
- Selective BRD9 degrader and inhibitor.
- High purity (>99%) suitable for research use.
- Applicable to in vitro and preclinical studies.
- Facilitates study of ncBAF complex and BRD9-related cancers.
- Molecular weight 829.00 and formula C47H56N8O6.
Medchemexpress LLC FHD-609 | 2676211-64-4 | C47H56N8O6 | 500 MG
FHD-609 is a PROTAC degrader and inhibitor of BRD9 (Bromodomain-containing protein 9), targeting ncBAF. It can be utilized for research into various cancers featuring mutations in a BAF complex subunit. This compound has demonstrated sustained BRD9 degradation and anti-tumor activities in preclinical models. In combination with Telomelysin or INO5401, FHD-609 may contribute to the treatment of adrenocortical carcinoma (ACC).
- Targets ncBAF
- Used for research into cancers with BAF complex subunit mutations
- Exhibits anti-tumor activities in preclinical models
- May be useful in adrenocortical carcinoma (ACC) treatment when combined with other agents
Selleck Chemical LLC 3-chloro-5-hydroxybenzoic Acid S5400-1g
3-chloro-5-hydroxybenzoic Acid is a selective agonist of the lactate receptor GPR81
eMolecules 71597-85-8 | 4-Hydroxyphenylboronic acid | Chem-Impex | MFCD01074628 | 137.930 | C6H7BO3 | 99.000 | OB(O)c1ccc(O)cc1 | 5g | 415099941
4-Hydroxyphenylboronic acid | Chem-Impex | 71597-85-8 | MFCD01074628 | 137.930 | C6H7BO3 | 99.000 | OB(O)c1ccc(O)cc1 | 5g | 415099941